TWVC Panglin Group Investment

Panglin TWVC is a venture capital firm and investment management group formed through a strategic partnership between the Panglin Group (Pengnian Group) and Tsinghua-Westlake Venture Capital. Headquartered in Shenzhen, the firm focuses on early-stage and growth-stage investments in the life sciences, biotechnology, and healthcare sectors. It leverages the scientific research capabilities of Tsinghua University and Westlake University to identify breakthrough technologies in drug discovery, diagnostics, and medical devices. The group is part of the philanthropic and investment legacy of Yu Pengnian, aiming to foster innovation that addresses significant unmet medical needs. Panglin TWVC plays a pivotal role in the biotech ecosystem of the Guangdong-Hong Kong-Macao Greater Bay Area by supporting academic spin-offs and high-barrier technical innovations.